Vivos Therapeutics (VVOS) Minority Interest (2025 - 2026)
Vivos Therapeutics' (VVOS) quarterly Minority Interest came in at -$171000.0 in Q2 2026, down 32.56% quarter-over-quarter from -$129000.0 in Q1 2026.
Powered by 
Analysis
Vivos Therapeutics (VVOS) Minority Interest (2025 - 2026) Analysis & Trends
Vivos Therapeutics (VVOS) has reported Minority Interest for 2 consecutive years, with -$171000.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Minority Interest changed N/A year-over-year to -$171000.0 in Q2 2026; TTM through Jun 2026 was -$171000.0, a N/A change from a year earlier, with the FY2025 full-year figure at -$60000.0, changed N/A from the prior year.
- Minority Interest was -$171000.0 for Q2 2026 at Vivos Therapeutics, down from -$129000.0 in the prior quarter.
- Over five years, Minority Interest peaked at -$60000.0 in Q4 2025 and troughed at -$171000.0 in Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Align Technology | 10.78 Bn | 9.68 Bn | 757.43 Mn |
| 2 | Envista Holdings | 4.18 Bn | 3.05 Bn | 407.00 Mn |
| 3 | Dentsply Sirona | 2.10 Bn | 1.86 Bn | 493.00 Mn |
| 4 | Milestone Scientific | 36.06 Mn | 33.45 Mn | 1.56 Mn |
| 5 | Dror Ortho-Design | 9.77 Mn | 9.68 Mn | - |
| 6 | Vivos Therapeutics | 3.21 Mn | 1.41 Mn | 2.95 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -171,000.00 |
| Mar 31, 2026 | -129,000.00 |
| Dec 31, 2025 | -60,000.00 |